Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 5,026 | 4,252 | 5,265 | 3,275 | 3,197 |
| Operating Income | -5,026 | -4,252 | -5,265 | -3,275 | -3,197 |
| Other Income | 17 | -21 | 2 | 2 | 2 |
| Pre-tax Income | -5,009 | -4,273 | -5,263 | -3,273 | -3,195 |
| Income Tax | -532 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -4,477 | -4,273 | -5,263 | -3,273 | -3,195 |
| Minority Interests | N/A | N/A | -2 | N/A | N/A |
| Net Income | $-4,477 | $-4,273 | $-5,261 | $-3,273 | $-3,195 |
| EPS Basic Total Ops | -7.00 | -7.75 | -2.75 | -6.25 | -6.00 |
| EPS Basic Continuous Ops | -7.06 | -7.73 | -10.04 | -6.20 | -6.05 |
| EPS Diluted Total Ops | -7.00 | -7.75 | -2.75 | -6.25 | -6.00 |
| EPS Diluted Continuous Ops | -7.06 | -7.73 | -10.04 | -6.20 | -6.05 |
| EBITDA(a) | $-5,008 | $-4,234 | $-5,252 | $-3,257 | $-3,174 |